Matthew Willett, MD
Ophthalmology · Kent, OHNPI 1457541104
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Aerie Pharmaceuticals, Inc. at 40.1% of the total. Reporting peaked in 2019 at $25,714 and has fallen 85.1% since, to $3,842 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $137.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerie Pharmaceuticals, Inc.$19K
- AbbVie$16K
- Sight Sciences, Inc.$6K
- Alcon$3K
- Glaukos Corporation$827
- Coopervision Inc.$606
- plus $3K from 20 others
Across 2 payments — averaging $6915.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$14K
What the payments were for
- Consulting fees$6,30013%
- Speaking & faculty fees$28,00559%
- Travel & lodging$4,3089%
- Food & beverage$8,73918%
- Education$820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | 36 | $19,031 |
| AbbVie(2 entities) | 104 | $15,530 |
| Sight Sciences, Inc. | 18 | $5,604 |
| Alcon | 70 | $2,752 |
| Glaukos Corporation | 12 | $827 |
| Coopervision Inc. | 5 | $606 |
| Bausch & Lomb Americas Inc. | 18 | $552 |
| Sun Pharmaceutical Industries Inc. | 4 | $539 |
| Johnson & Johnson Surgical Vision, Inc. | 13 | $485 |
| Harrow Eye, LLC | 8 | $259 |
| NEW World Medical,inc. | 6 | $227 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $170 |
| Novartis | 7 | $149 |
| Rxsight Inc | 3 | $121 |
| Biotissue Holdings Inc. | 1 | $105 |
| Kala Pharmaceuticals, Inc. | 5 | $79 |
| Mallinckrodt Hospital Products Inc. | 4 | $72 |
| Amgen | 3 | $64 |
| Oyster Point Pharma, Inc. | 4 | $61 |
| Dompe US, Inc. | 3 | $48 |
| Tarsus Pharmaceuticals, Inc. | 2 | $41 |
| Ivantis, Inc | 2 | $34 |
| Omeros Corporation | 2 | $27 |
| Shire North American Group Inc | 1 | $18 |
| Johnson & Johnson Vision Care, Inc. | 1 | $18 |
| Ocular Therapeutix, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rhopressa$18,407
- Rocklatan$18,407
- LUMIGAN$9,301
- OMNI(R) SURGICAL SYSTEM (US)$5,394
- SION SURGICAL INSTRUMENT$2,647
- SIMBRINZA$980
- COMBIGAN$800
- Non-Product Brand Specific$583
- iStent inject W$432
- XEN GLAUCOMA TREATMENT SYSTEM$251
- STELLARIS$155
- IACCESS$153
- Kahook Dual Blade$150
- Streamline Surgical System$150
- Ahmed Glaucoma Valve$150
- iDose$146
- ARGOS$143
- Tecnis IOL$132
- VEVYE$124
- Centurion$114
How this compares
$47,435 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 322 | $176,565 |
| RhopressaNetarsudil Mesylate | 199 | $115,668 |
| VyzultaLatanoprostene Bunod | 150 | $86,951 |
| RocklatanNetarsudil Mesylat/Latanoprost | 119 | $69,504 |
| Brimonidine Tartrate | 530 | $67,376 |
| CombiganBrimonidine Tartrate/Timolol | 90 | $35,497 |
| Alphagan PBrimonidine Tartrate | 57 | $33,217 |
| Prednisolone Acetate | 647 | $26,567 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 145 | $24,164 |
| Brinzolamide | 143 | $22,289 |
| Travoprost | 155 | $19,968 |
| Bimatoprost | 134 | $16,851 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 43 | $12,581 |
| MoxifloxacinMoxifloxacin Hcl | 390 | $11,032 |
| Pilocarpine Hcl | 185 | $10,578 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P | $15,530 | $245,278469 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $19,031 | $185,172318 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $552 | $86,951150 claims |
| AlconSimbrinza, Azopt | $2,752 | $21,93458 claims |
| NovartisTravatan Z | $149 | $4,99413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 640 ophthalmology providers in Ohio.
Other ophthalmology in Kent
- Elizabeth EsparazKent$10K
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
- Amy MillerDayton$526K
- Sunil SrivastavaCleveland$508K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.